C. Louvet

Antitumor activity of oxaliplatin in combination with 5-fluorouracil and the thymidylate synthase inhibitor AG337 in human colon, breast and ovarian cancers

Éric Raymond, Christine Buquet-Fagot, Siham Djelloul et al. · Anti-Cancer Drugs · 1997 · 237 citations

Prognostic and predictive value of the Immunoscore in stage III colon cancer patients treated with oxaliplatin in the prospective IDEA France PRODIGE-GERCOR cohort study

Franck Pagès, Thierry André, Déwi Vernerey et al. · Annals of Oncology · 2020 · 151 citations · Full text

Medicine, Cancer Management, Immunology +7

Final results of OPTIMOX2, a large randomized phase II study of maintenance therapy or chemotherapy-free intervals (CFI) after FOLFOX in patients with metastatic colorectal cancer (MRC): A GERCOR study

F. Maindrault-Gœbel, Gérard Lledo, Benoist Chibaudel et al. · Journal of Clinical Oncology · 2007 · 110 citations

Surgical Oncology, Cancer Management, Pathology +18

Thirteen-Month Registration of Patients with Gastroenteropancreatic Endocrine Tumours in France

Catherine Lombard‐Bohas, Emmanuel Mitry, Dermot O’Toole et al. · Neuroendocrinology · 2008 · 74 citations

Combined radiotherapy and chemotherapy (cisplatin and 5-fluorouracil) as palliative treatment for localized unresectable or adjuvant treatment for resected pancreatic adenocarcinoma: results of a feasibility study

Thierry André, Jacques Balosso, C. Louvet et al. · International Journal of Radiation Oncology*Biology*Physics · 2000 · 69 citations

Surgical Oncology, Pancreatic Cancer, Radiation Therapy +9